Page last updated: 2024-11-05

theobromine and Arterial Occlusive Diseases

theobromine has been researched along with Arterial Occlusive Diseases in 59 studies

Theobromine: 3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9)
theobromine : A dimethylxanthine having the two methyl groups located at positions 3 and 7. A purine alkaloid derived from the cacao plant, it is found in chocolate, as well as in a number of other foods, and is a vasodilator, diuretic and heart stimulator.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD)."9.06Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. ( Cobert, BL; Cohn, JB; Crowder, JE; Hryniewicki, SW; Morgan, DL; Piccirillo, RT; Savitsky, JP; Slywka, J; Wilcox, CS, 1989)
"Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo)."9.06Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. ( Ehrly, AM; Saeger-Lorenz, K, 1987)
"The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD)."5.06Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. ( Cobert, BL; Cohn, JB; Crowder, JE; Hryniewicki, SW; Morgan, DL; Piccirillo, RT; Savitsky, JP; Slywka, J; Wilcox, CS, 1989)
"Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo)."5.06Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. ( Ehrly, AM; Saeger-Lorenz, K, 1987)
"Pentoxifylline was significantly more effective than the placebo in increasing both the initial and absolute claudication distance (ICD and ACD) in patients with peripheral chronic occlusive arterial disease (COAD)."3.76Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease. ( Aggarwal, KK; Chopra, HK; Chopra, KL; Parashar, SK, 1988)
" infusion of pentoxifylline, administering 1,200 mg/24 hours through 15 days, was studied in 22 patients (19 m, 3 f) with arteriographically confirmed extensive occlusion in the femoro-popliteal segment, associated with marked intermittent claudication and rest pain of varying severity."3.67Continuous infusion treatment with pentoxifylline in patients with severe peripheral vascular occlusive disease. ( Angelides, NS, 1986)
"In an open clinical trial 14 patients with intermittent claudication caused by an obliteration of the femoral artery received 400 mg pentoxifylline 3 times daily over a period of 6 months."3.66[The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)]. ( Brock, FE; Nobbe, F; Rudofsky, G; Ulrich, M, 1979)
"Pentoxifylline was found both in healthy subjects and patients to significantly increase prostacyclin plasma concentration after i."2.66Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis. ( Boddi, M; Masotti, G; Poggesi, L; Scarti, L; Serneri, GG, 1985)
"Pentoxifylline was used in the treatment of 90 patients with atherosclerosis-induced chronic peripheral arterial occlusive disease and diabetic vascular disorders in the lower extremities (clinical Fontaine Stages III and IV) for whom surgical reconstructive treatment was not indicated and who had shown inadequate response to previous therapy."1.27Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease. ( Seige, K; Sternitzky, R, 1985)

Research

Studies (59)

TimeframeStudies, this research(%)All Research%
pre-199058 (98.31)18.7374
1990's1 (1.69)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maughan, RJ2
Broom, J1
Smith, G1
Leiper, JB1
Ah-See, AK1
Engeset, J1
Evan-Wong, A1
Davidson, RJ1
Ambrus, JL1
Ambrus, CM1
Taheri, SA1
Gastpar, H1
Reddington, MM1
Taheri, P1
Kahn, EA1
Schattman, GL1
Dean, LS1
Moore, RH1
Di Perri, T1
Carandente, O1
Vittoria, A1
Guerrini, M2
Messa, GL1
Grandillo, F1
Giunta, R1
Scognamiglio, G1
Tirelli, A1
Coppola, L1
Torella, R1
Benignetti, G1
Fabbri, F1
Benvenuti, C1
Angelkort, B5
Kiesewetter, H3
Trübestein, G2
Trübestein, R1
Duong, QD1
Accetto, B1
Porter, JM1
Cutler, BS1
Lee, BY2
Reich, T1
Reichle, FA1
Scogin, JT1
Strandness, DE1
Chmiel, H1
Anadere, I1
Heimburg, P1
Pecchi, S1
Rossi, C1
Cappelli, R1
Pieragalli, D1
Acciavatti, A1
Pupita, F1
Rotatori, P1
Frausini, G1
Küchle, HJ2
Richard, G2
Feruglio, FS1
Ponte, E1
Zaccaria, A1
Antonini, M1
Marciani, A1
Taurino, M1
Speziale, F1
Spartera, C1
Schoop, W1
Tannenberg, G1
Ehrly, AM4
Tonak, J1
Knecht, H1
Groitl, H1
Müller, R2
Nobbe, F2
von Westphalen, JG1
Sondern, W1
Leube, G1
Koshkin, VM1
Adil'khanov, SG1
Antonova, NIu1
Maurin, N1
Boateng, K1
Rudofsky, G3
Brock, FE1
Ulrich, M1
Störmer, B2
Kleinschmidt, F1
Loose, D2
Kremer, K2
Doppelfeld, E1
Völker, D1
Mund-Hoym, WD1
Lehrach, F1
Theis, H1
Kleinschmidt, K1
Smith, MA1
Fish, RC1
Schweiger, H1
Ortmeier, CJ1
Haussler, KF2
Künkel, HP2
Schneider-May, H2
Spengel, F2
Symann, O2
Werner, HJ2
Crowder, JE1
Cohn, JB1
Savitsky, JP2
Morgan, DL1
Slywka, J1
Cobert, BL1
Hryniewicki, SW1
Piccirillo, RT1
Wilcox, CS1
Lindgärde, F1
Jelnes, R1
Björkman, H1
Adielsson, G1
Kjellström, T1
Palmquist, I1
Stavenow, L1
von Bary, S1
Breddin, K1
Diehm, C1
Gruss, JD1
Heinrich, H1
Horsch, S1
Kriessmann, A1
Maass, U1
Martin, M1
Manrique, RV1
Manrique, V1
Chopra, HK1
Chopra, KL1
Aggarwal, KK1
Parashar, SK1
Rössner, M1
Blume, J2
Jung, F2
Gerhards, M2
Leipnitz, G2
Turowski, A1
Schmidt, HH1
Sternitzky, R2
Gleeson, M1
Saeger-Lorenz, K1
Loyd, RG1
Prian, GW1
Gomez, H1
Laub, J1
Mertz, GH1
Runge, E1
Thiele, P1
Perego, MA1
Sergio, G1
Artale, F1
Giunti, P1
Danese, C1
Angelides, NS1
Naide, D1
Poggesi, L1
Scarti, L1
Boddi, M1
Masotti, G1
Serneri, GG1
Berkowitz, P1
May, GS1
Brobst, J1
McCann, WJ1
Seige, K1

Reviews

4 reviews available for theobromine and Arterial Occlusive Diseases

ArticleYear
Pentoxifylline -- a biomedical profile.
    Journal of medicine, 1979, Volume: 10, Issue:5

    Topics: Arterial Occlusive Diseases; Blood Viscosity; Brain Ischemia; Cerebrovascular Circulation; Erythrocy

1979
Clinical considerations and treatment of diabetic angiopathy.
    Journal of medicine, 1979, Volume: 10, Issue:5

    Topics: Adult; Arterial Occlusive Diseases; Coronary Disease; Diabetic Angiopathies; Humans; Intermittent Cl

1979
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Journal of medicine, 1988, Volume: 19, Issue:2

    Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Hu

1988
[Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Wiener medizinische Wochenschrift (1946), 1986, Volume: 136 Spec No

    Topics: Arterial Occlusive Diseases; Chronic Disease; Combined Modality Therapy; Hemodilution; Humans; Pento

1986

Trials

16 trials available for theobromine and Arterial Occlusive Diseases

ArticleYear
Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
    Angiology, 1981, Volume: 32, Issue:10

    Topics: Adult; Aged; Analysis of Variance; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Bli

1981
Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.
    American heart journal, 1982, Volume: 103, Issue:5

    Topics: Adult; Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blind Me

1982
Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
    American heart journal, 1982, Volume: 104, Issue:1

    Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; E

1982
[Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
    Medizinische Monatsschrift, 1977, Volume: 31, Issue:10

    Topics: Aged; Ambulatory Care; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; F

1977
[Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1977, Jul-01, Volume: 119, Issue:26

    Topics: Adult; Aged; Arterial Occlusive Diseases; Blood; Clinical Trials as Topic; Female; Gait; Hemodynamic

1977
[Treatment of arterial diseases with trental 400. Results of a double-blind study].
    Die Medizinische Welt, 1978, Aug-11, Volume: 29, Issue:32

    Topics: Arterial Occlusive Diseases; Double-Blind Method; Drug Evaluation; Humans; Intermittent Claudication

1978
Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Angiology, 1989, Volume: 40, Issue:7

    Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Clinical Trials as Topic; Double-Blind Met

1989
Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
    Angiology, 1989, Volume: 40, Issue:9

    Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Electr

1989
Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group.
    Circulation, 1989, Volume: 80, Issue:6

    Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Double-Blind Method; Female; Humans; Intermittent

1989
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
    VASA. Supplementum, 1989, Volume: 28

    Topics: Aged; Alprostadil; Arterial Occlusive Diseases; Chronic Disease; Follow-Up Studies; Humans; Multicen

1989
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Journal of medicine, 1988, Volume: 19, Issue:2

    Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Hu

1988
[Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
    VASA. Supplementum, 1987, Volume: 20

    Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; Humans; Infusions, Intra

1987
[Training by walking and drug therapy of peripheral arterial occlusive disease].
    VASA. Supplementum, 1987, Volume: 20

    Topics: Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind

1987
Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
    Angiology, 1987, Volume: 38, Issue:2 Pt 1

    Topics: Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Exercise Test; Humans; Inter

1987
[Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Deutsche medizinische Wochenschrift (1946), 1987, May-29, Volume: 112, Issue:22

    Topics: Administration, Oral; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality

1987
Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Angiology, 1985, Volume: 36, Issue:9

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arterial Occlusive Diseases; Blood Flow Velocity; Clinical Tria

1985

Other Studies

40 other studies available for theobromine and Arterial Occlusive Diseases

ArticleYear
Whole blood and red cell ATP content in patients with peripheral vascular disease: the effect of cigarette smoking and oxpentifylline.
    Angiology, 1984, Volume: 35, Issue:10

    Topics: Adenosine Triphosphate; Age Factors; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Erythrocyt

1984
Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches.
    Angiology, 1984, Volume: 35, Issue:7

    Topics: Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Blood Viscosity; Drug Therapy, Combination; F

1984
Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
    Angiology, 1984, Volume: 35, Issue:7

    Topics: Alprostadil; Animals; Antifibrinolytic Agents; Arterial Occlusive Diseases; Blood Platelets; Drug Sy

1984
[Effect of pentoxifylline on the dissociation curve of oxyhemoglobin].
    Il Farmaco; edizione scientifica, 1983, Volume: 38, Issue:1

    Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Male; Oxygen Consumption; Oxyhemoglobins; Pentoxi

1983
[Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    La Clinica terapeutica, 1983, Feb-28, Volume: 104, Issue:4

    Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Female; Humans; Male; Middle Aged; Pentoxifyllin

1983
Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
    Scandinavian journal of clinical and laboratory investigation. Supplementum, 1981, Volume: 156

    Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Coagulation; Blood Flow Velocity; Chronic

1981
The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
    La Ricerca in clinica e in laboratorio, 1981, Volume: 11 Suppl 1

    Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Elasticity; Female; Hematocrit; Humans; Injectio

1981
[Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    La Ricerca in clinica e in laboratorio, 1981, Volume: 11 Suppl 1

    Topics: Arterial Occlusive Diseases; Blood Viscosity; Heart Rate; Humans; Muscles; Pentoxifylline; Theobromi

1981
[Clinical pharmacology of vasoactive substances: study on pentoxifylline].
    La Ricerca in clinica e in laboratorio, 1981, Volume: 11 Suppl 1

    Topics: Aged; Arterial Occlusive Diseases; Drug Evaluation; Female; Heart Rate; Humans; Male; Middle Aged; M

1981
The effect of pentoxifylline on circulatory disturbances of the retina and optic nerve. A report of ten years clinical experience.
    La Ricerca in clinica e in laboratorio, 1981, Volume: 11 Suppl 1

    Topics: Arterial Occlusive Diseases; Humans; Optic Nerve Diseases; Pentoxifylline; Retinal Artery; Retinal D

1981
[Clinical aspects of hemorrheology in the aged: possibility of prevention and therapy].
    La Ricerca in clinica e in laboratorio, 1981, Volume: 11 Suppl 1

    Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Intracranial Arteriosclerosis; Leg; Male; Middle

1981
[Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
    La Ricerca in clinica e in laboratorio, 1981, Volume: 11 Suppl 1

    Topics: Aged; Arterial Occlusive Diseases; Drug Evaluation; Female; Humans; Leg; Male; Middle Aged; Pentoxif

1981
[Worsening of arterial occlusive diseases by pentoxifylline?].
    Deutsche medizinische Wochenschrift (1946), 1980, Jan-25, Volume: 105, Issue:4

    Topics: Arterial Occlusive Diseases; Humans; Pentoxifylline; Theobromine

1980
[Drug therapy of arterial diseases. A study with Trental 400].
    Fortschritte der Medizin, 1980, Dec-04, Volume: 98, Issue:45

    Topics: Adult; Arterial Occlusive Diseases; Blood Pressure; Drug Evaluation; Drug Tolerance; Humans; Male; M

1980
The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Journal of medicine, 1979, Volume: 10, Issue:5

    Topics: Arterial Occlusive Diseases; Blood Viscosity; Erythrocytes; Humans; Microcirculation; Muscles; Oxyge

1979
[Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Die Medizinische Welt, 1979, Aug-24, Volume: 30, Issue:34

    Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation; Blood Platelets; Chronic Disease; Femal

1979
[Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
    Die Medizinische Welt, 1979, Sep-14, Volume: 30, Issue:37

    Topics: Aged; Ambulatory Care; Arterial Occlusive Diseases; Evaluation Studies as Topic; Female; Germany, We

1979
[Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
    Vestnik khirurgii imeni I. I. Grekova, 1979, Volume: 123, Issue:12

    Topics: Acute Disease; Arterial Occlusive Diseases; Blood Circulation; Drug Evaluation; Embolism; Hemodynami

1979
Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Current medical research and opinion, 1979, Volume: 6, Issue:4

    Topics: Adult; Aged; Arterial Occlusive Diseases; Erythrocytes; Humans; Middle Aged; Pentoxifylline; Regiona

1979
[Therapy of arterial vascular occlusions of retinal and optic nerve (author's transl)].
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1979, Volume: 179, Issue:5

    Topics: Administration, Oral; Arterial Occlusive Diseases; Humans; Optic Nerve; Pentoxifylline; Retinal Arte

1979
[The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
    Medizinische Klinik, 1979, Jul-13, Volume: 74, Issue:28-29

    Topics: Arterial Occlusive Diseases; Exercise Therapy; Femoral Artery; Humans; Hyperemia; Intermittent Claud

1979
[Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1978, Apr-21, Volume: 103, Issue:16

    Topics: Arterial Occlusive Diseases; Bencyclane; Blood Proteins; Blood Viscosity; Cycloheptanes; Humans; Mat

1978
[Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Medizinische Klinik, 1978, May-26, Volume: 73, Issue:21

    Topics: Aged; Arm; Arterial Occlusive Diseases; Blood Flow Velocity; Chronic Disease; Drug Evaluation; Femal

1978
The effect of pentoxifylline on the flow properties of human blood.
    Current medical research and opinion, 1978, Volume: 5, Issue:8

    Topics: Arterial Occlusive Diseases; Erythrocyte Count; Erythrocytes; Humans; In Vitro Techniques; Osmolar C

1978
[The treatment of chronic arterial bloodcirculation interference (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Oct-24, Volume: 67, Issue:43

    Topics: Adult; Aged; Arterial Occlusive Diseases; Cholesterol; Drug Evaluation; Female; Humans; Leg; Leg Ulc

1978
[5 years of clinico-experimental and therapeutic experiences with pentoxifylline].
    Medizinische Monatsschrift, 1977, Volume: 31, Issue:4

    Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Chemical Phenomena; Chemistry; Eye Diseases;

1977
Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs.
    Current medical research and opinion, 1977, Volume: 4, Issue:8

    Topics: Arterial Occlusive Diseases; Bencyclane; Blood Viscosity; Chronic Disease; Cycloheptanes; Humans; Pe

1977
Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Angiology, 1976, Volume: 27, Issue:3

    Topics: Adenosine Triphosphate; Ancrod; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; E

1976
Clinical results of pentoxifylline use in a community peripheral vascular surgical practice.
    Monographs on atherosclerosis, 1990, Volume: 15

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Humans; Male; Midd

1990
Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
    Pharmatherapeutica, 1989, Volume: 5, Issue:5

    Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Exercise Test; Female; Hemodynamics; Human

1989
Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
    Angiology, 1987, Volume: 38, Issue:2 Pt 1

    Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cyclic AMP; Drug Resist

1987
[Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Zeitschrift fur arztliche Fortbildung, 1987, Volume: 81, Issue:17

    Topics: Arterial Occlusive Diseases; Blood Cell Count; Blood Viscosity; Exercise Test; Female; Hematocrit; H

1987
Adenine nucleotides in erythrocytes from patients with peripheral vascular disease and the effects of oxpentifylline.
    European journal of vascular surgery, 1987, Volume: 1, Issue:3

    Topics: Adenine Nucleotides; Adult; Aged; Arterial Occlusive Diseases; Cells, Cultured; Erythrocyte Deformab

1987
Failure of pentoxifylline for end-stage peripheral vascular disease.
    Angiology, 1987, Volume: 38, Issue:4

    Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Coronary Disease; Humans; Intermittent Claudic

1987
[Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1987, Mar-01, Volume: 42, Issue:5

    Topics: Adult; Arterial Occlusive Diseases; Aspirin; Blood Viscosity; Drug Therapy, Combination; Female; Hum

1987
Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
    Current medical research and opinion, 1986, Volume: 10, Issue:2

    Topics: Aged; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Humans;

1986
Continuous infusion treatment with pentoxifylline in patients with severe peripheral vascular occlusive disease.
    Angiology, 1986, Volume: 37, Issue:8

    Topics: Arterial Occlusive Diseases; Blood Pressure; Female; Femoral Artery; Humans; Infusions, Parenteral;

1986
Drug therapy for peripheral arterial disease.
    American family physician, 1986, Volume: 34, Issue:3

    Topics: Arterial Occlusive Diseases; Calcium Channel Blockers; Dipyridamole; Humans; Pentoxifylline; Theobro

1986
Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
    Clinical cardiology, 1985, Volume: 8, Issue:3

    Topics: Aged; Arterial Occlusive Diseases; Exercise Test; Humans; Intermittent Claudication; Ischemia; Leg;

1985
Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease.
    Current medical research and opinion, 1985, Volume: 9, Issue:9

    Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mell

1985